Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PIOGLITAZONE | 15MG | TABLET | Resolved | 2019-07-04 | 2023-01-03 | 88502 |
| MINT-PIOGLITAZONE | 30MG | TABLET | Resolved | 2019-10-09 | 2023-01-03 | 95924 |
| MINT-PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-04-25 | 2023-01-03 | 113196 |
| MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
| MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
| MINT-AMLODIPINE | 5MG | TABLET | Resolved | 2017-11-21 | 2018-01-11 | 30002 |
| MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
| MINT-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95932 |
| MINT-SIMVASTATIN | 40MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95935 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35489 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95938 |
| MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
| MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-02-04 | 2020-01-27 | 74450 |
| MINT-LOSARTAN/HCTZ | 50MG 12.5MG | TABLET | Resolved | 2020-04-25 | 2020-07-13 | 113193 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80808 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-10-21 | 2023-04-01 | 147787 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |